Concordare (undisclosed)
Funding Details
Awarder
Inbox
Date Award
August 26, 2026
Vertical
Venture Capital and Private Equity
Company Info
Founders
Zach Sawaged
Market
Clinical Trials
Location
New York, NY, USA
Coinvestors
Gaingels, Innovation Works, Surface Ventures, TechStars
Company Description

The Concordare Suite ingests any protocol PDF and converts it into the company's proprietary CTPM (Clinical Trial Protocol Model), a digital, system-agnostic source of truth for a trial. AI is used exclusively for protocol extraction. The CTPM is human-reviewed before generating system configurations and study documents, maintaining protocol fidelity and study integrity.

Links